Cannabis microbiome sequencing and its implications for cannabis safety testing

被引:0
|
作者
Boyar, Kyle [1 ]
机构
[1] Med Genom, San Diego, CA USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
29
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Cannabis: Implications for Workplace Health and Safety
    Phillips, Jennan
    WORKPLACE HEALTH & SAFETY, 2020, 68 (12) : 569 - 570
  • [2] GC methods for Cannabis safety and potency testing
    Rigdon, Amanda
    Cochran, Jack
    Hilliard, Corby
    Schroeder, William
    Schroeder, Christi
    Flood, Theo
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [3] Cannabis legalisation and testing for cannabis use in safety- and risk-sensitive environments
    Laurens, J. B.
    Carstens, P. A.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2020, 110 (10): : 995 - 998
  • [4] CANNABIS SAFETY
    Kemsley, Jyllian
    CHEMICAL & ENGINEERING NEWS, 2015, 93 (16) : 27 - 28
  • [5] Cannabis: Workplace Implications of Employee Cannabis Use
    Gifford-Meuleveld, Linda
    WORKPLACE HEALTH & SAFETY, 2017, 65 (09) : 403 - 404
  • [6] Medicinal Cannabis and the Intestinal Microbiome
    Vitetta, Luis
    Nation, Tamara
    Oldfield, Debbie
    Thomsen, Michael
    PHARMACEUTICALS, 2024, 17 (12)
  • [7] The Cannabis Act: implications for human participant research with cannabis
    Di Ciano, Patricia
    Wickens, Christine
    Paul, Elvin M.
    Mahmood, Raesham
    Crepault, Jean-Francois
    Rueda, Sergio
    Boileau, Isabelle
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2024, 49 (03): : E212 - E217
  • [9] Sleep Disturbances: Implications for Cannabis Use, Cannabis Use Cessation, and Cannabis Use Treatment
    Babson K.A.
    Bonn-Miller M.O.
    Current Addiction Reports, 2014, 1 (2) : 109 - 114
  • [10] Costs of cannabis testing compliance: Assessing mandatory testing in the California cannabis market
    Valdes-Donoso, Pablo
    Sumner, Daniel A.
    Goldstein, Robin
    PLOS ONE, 2020, 15 (04):